Our research showed that Artemisinin and its derivatives Dihydroartemisinin and Artesunate suppress cancers such as melanoma, breast cancer, and lung cancer, especially melanoma growth, recurrence, and metastasis, and prolong the survival lifespan through the KIT/PI3K/AKT signaling pathway after radical cancer surgery. This evidence concerns the gene AKT1 and lung cancer.